(Q40676140)

22 September 2017

1 reference

title

Down-regulation of cytokine action (English)

1 reference

22 September 2017

McCarthy PL

1

1 reference

22 September 2017

publication date

1 March 1994

1 reference

Best Practice and Research: Clinical Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

7

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

153-177

1 reference

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Cytokines: coordinators of immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Autoantibodies to cytokines--friends or foes?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

A critical evaluation of new agents for the treatment of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Role of interleukin-1 in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Soluble cytokine receptors: their role in immunoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

In human monocytes interleukin-1 stimulates a phospholipase C active on phosphatidylcholine and inactive on phosphatidylinositol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Anti-interleukin-6 antibodies in normal human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

The p70 tumor necrosis factor receptor mediates cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Leukemia inhibitory factor: a biological perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Effects of anti-TNF monoclonal antibody infusion in patients with hairy cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Herbimycin A blocks IL-1-induced NF-kappa B DNA-binding activity in lymphoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interactions between cytokines and α2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin-4. A regulatory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Demonstration of two distinct forms of released low-affinity type interleukin 2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

The cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

1 reference

7 January 2021

Cytokines in antibacterial resistance: possible applications for immunomodulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Transforming growth factor-beta: a bidirectional regulator of hematopoietic cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin-1 generates transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

A soluble 'anchorminus' interleukin 2 receptor suppresses in vitro interleukin 2-mediated immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Growth hormone receptor and serum binding protein: purification, cloning and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Cytokine regulation of endothelial cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Negative regulation of gene expression by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Astrocyte mitogen inhibitor related to epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Soluble cytokine receptors are present in normal human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Molecular characterization of interleukin 12

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Use of a soluble interleukin-1 receptor to inhibit ocular inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Identification of a soluble GM-CSF binding protein in the supernatant of a human choriocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Purification and characterization of a novel soluble receptor for interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Molecular cloning and expression of the murine interleukin-5 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Human TNF mutants with selective activity on the p55 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Purification of natural human IFN-gamma antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: Downregulation of inflammatory cytokine (TNF, IL-6) release

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

Molecular mechanisms for generation of neural diversity and specificity: roles of polypeptide factors in development of postmitotic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980011-3

7 January 2021

10.1016/S0950-3536(05)80011-3

Identifiers

DOI

1 reference

22 September 2017

1 reference